Tumor necrosis factor inhibition: A part of the solution or a part of the problem of heart failure in rheumatoid arthritis?
Open Access
- 29 February 2008
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 58 (3), 637-640
- https://doi.org/10.1002/art.23280
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics RegisterArthritis & Rheumatism, 2007
- All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonistsAnnals Of The Rheumatic Diseases, 2007
- Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritisArthritis & Rheumatism, 2006
- Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritisRheumatology, 2005
- Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long‐term treatment with anti–tumor necrosis factor α antibodyArthritis Care & Research, 2004
- Making an impact on mortality in rheumatoid arthritis: Targeting cardiovascular comorbidityArthritis & Rheumatism, 2004
- Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti–tumor necrosis factor therapyAmerican Journal Of Medicine, 2004
- Survival in rheumatoid arthritis: A population‐based analysis of trends over 40 yearsArthritis & Rheumatism, 2003
- Methotrexate and mortality in patients with rheumatoid arthritis: a prospective studyThe Lancet, 2002
- Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidityThe Lancet, 2000